ArticleJournal of microbiology and biotechnology2026
Multifunctional Skin Dermal Extracellular Matrix Enabling Skin-Relevant Bioactivity for Tissue Remodeling, Hydration, and Anti-Hyperpigmentation.
Article in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermal extracellular matrix (ECM) deterioration is a central driver of skin aging, contributing to impaired elasticity, decreased moisturization, and uneven pigmentation. However, commonly used single-component ingredients and cell-derived bioactives provide limited coordinated cues and may therefore be insufficient to address these multifactorial processes. Here, we propose decellularized skin-derived ECM (skin ECM) as a multifunctional cosmetic ingredient through comparison with various existing cosmetic ingredients. Proteomic analysis shows that skin ECM retains diverse collagen subtypes along with glycoproteins and proteoglycans associated with dermal tensile properties and matrix regulation, more closely reflecting native dermal matrisome diversity than commercial collagen products. Skin ECM at an optimal concentration most effectively upregulates the expression of genes involved in ECM remodeling and hyaluronan-mediated hydration in human dermal fibroblasts. In comparative supplementation assay, skin ECM enhances fibroblast metabolic activity and induces the strongest expression of key ECM- and hydration-related genes among all tested ingredients. Interestingly, skin ECM reduces the expression of melanogenesis-related markers and melanin accumulation in melanoma cells under experimental conditions with α-melanocyte stimulating hormone treatment. Collectively, these findings highlight the potential of skin ECM for cosmetic applications to improve overall skin conditioning and its broader promise for anti-skin aging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.